Device type · CIB
Radioimmunoassay, Angiotensin I And Renin
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
CIB
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Radioimmunoassay, Angiotensin I And Renin
- Product code
- CIB
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1085
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for CIB
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0016-2013 · Started Jan 20, 2012 · Posted by FDA Oct 5, 2012
Reason given: The recall was initiated because Beckman Coulter has confirmed that the Active Renin IRMA Test Kit may exhibit a decrease in stability of the coated tubes. As a result, quality control and patient sample results may be falsely elevated by up to 72%.
Cause as FDA categorized it: Nonconforming Material/Component
Z-1914-2010 · Started Oct 12, 2009 · Posted by FDA Jun 28, 2010
Reason given: The kit control provided with the GammaCoat Plasma Renin Activity kit was labeled with the incorrect range.
Cause as FDA categorized it: Nonconforming Material/Component
Perkinelmer Life Sciences, Inc.
Z-1206-03 · Started Jul 28, 2003 · Posted by FDA Sep 12, 2003
Reason given: Incorrect calibration standard value may result in 25% higher assay values for controls and patient samples
Cause as FDA categorized it: Other
1 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.